CLOs on the Move

Element451

www.element451.com

 
Element451 is an advanced student engagement CRM, providing higher ed institutions with a competitive admissions advantage from recruitment to enrollment through the use of AI, student behavior data, and modern marketing automation. The Element451 CRM leverages millions of behavior-based data insights to reach prospective students where they are -- both in their journey and in their preferred channel. Supporting these insights is a full complement of marketing best practices and AI-driven automation to ensure the right message reaches the right student at the right time. All of the data, analytics and insights are available to the entire admissions team through ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Infima Technologies

Infima is a capital market technology startup company building transformative prediction services for the $25T credit market. Our disruptive deep learning technologies deliver actionable predictions of borrower, security and market behavior that set new accuracy and latency standards in the market. Our predictions provide new, performance-boosting edges for investors and dealers, thus making them a must-have for many market participants. We are backed by leading venture capital and strategic investors.

SwiftConnect

We digitize the workplace experience - connecting the right people to the right spaces at the right time. #hybridwork #swiftconnect

Boasso Global

Boasso Global provides ISO Container Services including cleaning, storage, repairs, heating, and transportation through its state-of-the-art container depots. Find a strategically placed depot location in the United States or United Kingdom near you to...

Innovatech Associates Rocky Mountains

Innovatech Associates Rocky Mountains is a Lakewood, CO-based company in the Software and Internet sector.

Valo Therapeutics

Valo Tx is developing PeptiCRAd Technology: A platform for targeted cancer immunotherapy that synergistically combines oncolytic viruses and peptide vaccines